Anti-mouse Ly6G/Ly6C (Gr-1) Antibody (Clone:RB6-8C5) | PA007627.r2b

Recombinant Anti-mouse Ly6G/Ly6C (Gr-1) Monoclonal Antibody (RB6-8C5), In Vivo PA007627.r2b Syd Labs

Anti-mouse Ly6G/Ly6C (Gr-1) Antibody (Clone:RB6-8C5) | PA007627.r2b

$150.00 – $900.00

In stock

$150.00 – $900.00

Recombinant rat IgG2b isotype controls are available. Condition of sample preparation and optimal sample dilution should be determined experimentally by the investigator.

Clear
View cart
Order Offline:
Phone: 1-617-401-8149
Fax: 1-617-606-5019
Email: message@sydlabs.com
Catalog No. PA007627.r2b
Product Name In Vivo Grade Recombinant Anti-mouse Ly6G/Ly6C (Gr-1) Monoclonal Antibody (Clone: RB6-8C5), Rat IgG2b Kappa
Supplier Name Syd Labs, Inc.
Brand Name Syd Labs
Synonyms Gr-1, Gr1, Ly-6G, ly-6G.1, ly6C
Clone RB6-8C5.
Isotype Rat IgG2b Kappa.
Source/Host The anti-mouse Ly6G/Ly6C (Gr-1) monoclonal antibody (clone: RB6-8C5) was produced in mammalian cells.
Specificity/Sensitivity The in vivo grade recombinant rat monoclonal antibody (clone: RB6-8C5) specifically binds to mouse Ly6G/Ly6C (Gr-1).
Applications ELISA, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by the mouse Ly6G/Ly6C (Gr-1) protein.
Form Of Antibody 0.2 uM filtered solution, pH 7.4, no stabilizers or preservatives.
Endotoxin < 1 EU per 1 mg of the protein by the LAL method.
Purity >95% by SDS-PAGE under reducing conditions and HPLC.
Shipping The in vivo grade recombinant anti-mouse Ly6G/Ly6C (Gr-1) monoclonal antibody of clone RB6-8C5 is shipped with ice pack. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70°C as supplied. 1 month from date of receipt, 2 to 8°C as supplied.
Note Recombinant rat IgG2b isotype controls are available. Condition of sample preparation and optimal sample dilution should be determined experimentally by the investigator.
Order Offline Phone: 1-617-401-8149 Fax: 1-617-606-5022 Email: message@sydlabs.com Or leave a message with a formal purchase order (PO) Or credit card.

Description

PA007627.r2b: In Vivo Grade Recombinant Anti-mouse Ly6G/Ly6C (Gr-1) Monoclonal Antibody (Clone: RB6-8C5), Rat IgG2b Kappa

Recombinant rat IgG2b Monoclonal Antibody.

References of Anti-Mouse Ly6G/Ly6C (Gr-1) Monoclonal Antibody (Clone: RB6-8C5)

1. P2RX7 sensitizes Mac-1/ICAM-1-dependent leukocyte-endothelial adhesion and promotes neurovascular injury during septic encephalopathy.
Wang, H., et al.Cell Res. 2015 Jun;25(6):674-90. doi: 10.1038/cr.2015.61. PMID: 25998681
“To further confirm the correlation between leukocyte-endothelial adhesion and microglial activation, we depleted leukocytes using an anti-granulocyte receptor-1 (Gr-1) monoclonal antibody (mAb, RB6-8C5). …Treatment with RB6-8C5 significantly suppressed microglial activation. …Flow cytometry analysis of the surface expression of CD11a/CD18, CD11b/CD18 and CD18 on leukocytes (labeled by Ly6G staining) from peripheral blood of Sham mice and CLP (4 h) mice. …For neutrophil depletion, mice were treated with intraperitoneal injection of 250 µg anti-granulocyte receptor-1 (Gr-1) mAb RB6-8C5 (BioXCell, West Lebanon, NH, USA) or an isotype control (BioXCell) 24 h prior to CLP surgery. …The number of adherent leukocytes (loosely adherent/arrested or firmly adherent) at 4 h post-CLP was increased by 458 ± 102/mm² compared to that in the sham mice (26 ± 10/mm²).”

2. Tumor-derived G-CSF facilitates neoplastic growth through a granulocytic myeloid-derived suppressor cell-dependent mechanism.
Waight, J. D., et al.PLoS One. 2011;6(11):e27690. doi: 10.1371/journal.pone.0027690. PMID: 22110722
“In mouse models MDSC are broadly defined as CD11b+Gr-1+ cells. …More recently, MDSC have been divided into monocytic and granulocytic subsets, reflecting differential expression of the Ly6C and Ly6G epitopes. …Monocytic MDSC are characterized as CD11b+Ly6C high Ly6G- or CD11b+Gr-1 low cells whereas granulocytic MDSC are defined as CD11b+Ly6C low Ly6G+ cells or CD11b+Gr-1 high. …Using these additional phenotypic markers, splenocytes from G-CSF-treated mice displayed a prominent expansion of granulocytic-like cells (81.4% granulocytic vs. 8.2% monocytic) compared to control mice (23.5% granulocytic vs. 16.9% monocytic). …Third, to delineate which MDSC subset(s) were affected most, we analyzed these preparations for granulocytic and monocytic fractions based on differential expression of the Ly6C and Ly6G epitopes in the gated CD11b+ fraction.”

For more technical references or data sheets regarding the Recombinant Anti-Mouse Ly6G/Ly6C (Gr-1) Monoclonal Antibody (Clone: RB6-8C5) formats, please contact our scientific support team at message@sydlabs.com.

In Vivo Grade Recombinant Anti-mouse Ly6G/Ly6C (Gr-1) Monoclonal Antibody (Clone: RB6-8C5), Rat IgG2b Kappa from: In Vivo Grade Recombinant Anti-mouse Ly6G/Ly6C (Gr-1) Monoclonal Antibody (Clone: RB6-8C5), Rat IgG2b Kappa: PA007627.r2b